Literature DB >> 24265044

Extracranial Segments of the Vertebral Artery: Insight in the Developmental Changes up to the 21st Year of Life.

Vasović Ljiljana1, Jovanović Ivan, Ugrenović Slađana, Vlajković Slobodan, Jovanović Predrag, Dorđević Gordana.   

Abstract

The vertebral artery (VA) bilaterally arises usually from the subclavian artery and courses within the bony canals of cervical vertebrae, and then it reverses directions on the first vertebra before piercing the dura to enter the cranium.The aim was to follow (ab)normal developmental changes of extracranial VA from prenatal status to age 21. This chapter included a brief description of the arterial embryology and morphofunctional specificity of the VA in prevertebral, cervical, and atlantic parts, during prenatal and postnatal period.The authors concluded that the subclavian origin of the VA was in most of fetal and adult cases. The incidences of variable VA origins and domination of one of the VAs were different from one series of human specimens to the second one. Although in most of cases, anomalous origin and/or variable course of the extracranial VA had little or did not result in clinical symptoms in infants and young adults, the true value of their discovery is in the diagnostic gain before vascular surgery of supra-aortic arteries.

Entities:  

Mesh:

Year:  2014        PMID: 24265044     DOI: 10.1007/978-3-319-01065-6_3

Source DB:  PubMed          Journal:  Adv Tech Stand Neurosurg        ISSN: 0095-4829


  2 in total

1.  Variation of some arteries of the vertebrobasilar system: case report.

Authors:  Borisav Stojanović; Ljiljana Vasović; Slobodan Vlajković; Milena Trandafilović; Marija Mladenović
Journal:  Surg Radiol Anat       Date:  2016-10-21       Impact factor: 1.246

Review 2.  Unilateral Aplasia versus Bilateral Aplasia of the Vertebral Artery: A Review of Associated Abnormalities.

Authors:  L Vasović; M Trandafilović; S Vlajković; G Djordjević; M Daković-Bjelaković; M Pavlović
Journal:  Biomed Res Int       Date:  2017-08-28       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.